XEROX CORP (XRX) is a publicly traded company in the Unknown sector. Across all available filings, 63 corporate insiders have executed 1014 transactions totaling $776.3M, demonstrating a bearish sentiment with -$478.3M in net insider flow. The most recent transaction on Feb 4, 2026 involved a transaction of 20,986 shares valued at $48.1K.
No significant insider buying has been recorded for XRX in the recent period.
No significant insider selling has been recorded for XRX in the recent period.
Based on recent SEC filings, insider sentiment for XRX is bearish with an Insider Alignment Score of 19/100 and a net flow of -$478.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at XEROX CORP (XRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 63 insiders are actively trading XRX stock, having executed 1014 transactions in the past 90 days. The most active insider is Partners Master Fund Lp Icahn (Executive), who has made 7 transactions totaling $612.9M.
Get notified when executives and directors at XRX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 4, 2026 | John Bandrowczak Steven | Executive | Payment | 20,986 | $2.29 | $48.1K | |
| Feb 4, 2026 | John Bandrowczak Steven | Executive | Award | 66,960 | $N/A | $0 | |
| Feb 4, 2026 | Gueden Jacques-edouard | See Remarks | Payment | 7,000 | $2.29 | $16.0K | |
| Feb 4, 2026 | Gueden Jacques-edouard | See Remarks | Award | 12,499 | $N/A | $0 | |
| Feb 4, 2026 | Colon Flor | See Remarks | Payment | 1,016 | $2.29 | $2.3K | |
| Feb 4, 2026 | Colon Flor | See Remarks | Award | 2,456 | $N/A | $0 | |
| Aug 2, 2025 | John Bandrowczak Steven | Executive | Payment | 27,837 | $3.94 | $109.7K | |
| Aug 2, 2025 | John Bandrowczak Steven | Executive | Option Exercise | 60,071 | $N/A | $0 | |
| Aug 2, 2025 | John Bandrowczak Steven | Executive | Option Exercise | 60,071 | $N/A | $0 | |
| Aug 1, 2025 | Scott Letier A. | Executive | Purchase | 29,600 | $3.95 | $116.9K | |
| Aug 1, 2025 | Gecaj Mirlanda | Executive | Purchase | 5,179 | $4.03 | $20.9K | |
| Jul 20, 2025 | Gecaj Mirlanda | Executive | Payment | 523 | $5.07 | $2.7K | |
| Jul 20, 2025 | Gecaj Mirlanda | Executive | Option Exercise | 1,214 | $N/A | $0 | |
| Jul 20, 2025 | Gecaj Mirlanda | Executive | Option Exercise | 1,214 | $N/A | $0 | |
| Aug 2, 2024 | John Bandrowczak Steven | Executive | Payment | 27,019 | $10.14 | $274.0K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 55 | $627.3M | 63.0% |
Purchase(P) | 31 | $149.0M | 15.0% |
Award(A) | 321 | $82.2M | 8.3% |
Other(J) | 6 | $54.6M | 5.5% |
Payment(F) | 248 | $42.8M | 4.3% |
Exercise(M) | 349 | $40.0M | 4.0% |
Gift(G) | 4 | $0 | 0.0% |
Insider selling pressure at XEROX CORP has increased, with 63 insiders executing 1014 transactions across all time. Total sales of $627.3M significantly outpace purchases of $149.0M, resulting in a net outflow of $478.3M. This selling activity appears largely discretionary, which may warrant closer attention from investors.